ERBB2 (erb-b2 receptor tyrosine kinase 2), also known as HER2, showed spatial patterns in most breast cancer tissue samples, and particularly, was highly expressed in the tumor region, as reported to be overexpressed in ∼30% of human breast cancers (85). This evidence concerns the gene ERBB2 and breast carcinoma.